NM_001101426.4:c.*3275_*3282delAAAAAAAA
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001101426.4(CRPPA):c.*3275_*3282delAAAAAAAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.37 ( 7439 hom., cov: 0)
Failed GnomAD Quality Control
Consequence
CRPPA
NM_001101426.4 3_prime_UTR
NM_001101426.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.13
Publications
0 publications found
Genes affected
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
CRPPA Gene-Disease associations (from GenCC):
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- myopathy caused by variation in CRPPAInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2UInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy without intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 7-16088412-CTTTTTTTT-C is Benign according to our data. Variant chr7-16088412-CTTTTTTTT-C is described in ClinVar as [Benign]. Clinvar id is 359494.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.573 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRPPA | NM_001101426.4 | c.*3275_*3282delAAAAAAAA | 3_prime_UTR_variant | Exon 10 of 10 | ENST00000407010.7 | NP_001094896.1 | ||
CRPPA | NR_160656.1 | n.4696_4703delAAAAAAAA | non_coding_transcript_exon_variant | Exon 8 of 8 | ||||
CRPPA | NM_001368197.1 | c.*3275_*3282delAAAAAAAA | 3_prime_UTR_variant | Exon 9 of 9 | NP_001355126.1 | |||
CRPPA | NM_001101417.4 | c.*3275_*3282delAAAAAAAA | 3_prime_UTR_variant | Exon 9 of 9 | NP_001094887.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.375 AC: 42444AN: 113208Hom.: 7435 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
42444
AN:
113208
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.375 AC: 42424AN: 113192Hom.: 7439 Cov.: 0 AF XY: 0.384 AC XY: 20170AN XY: 52580 show subpopulations
GnomAD4 genome
AF:
AC:
42424
AN:
113192
Hom.:
Cov.:
0
AF XY:
AC XY:
20170
AN XY:
52580
show subpopulations
African (AFR)
AF:
AC:
4567
AN:
27660
American (AMR)
AF:
AC:
4243
AN:
9534
Ashkenazi Jewish (ASJ)
AF:
AC:
810
AN:
2944
East Asian (EAS)
AF:
AC:
1436
AN:
3672
South Asian (SAS)
AF:
AC:
2260
AN:
3810
European-Finnish (FIN)
AF:
AC:
2576
AN:
4548
Middle Eastern (MID)
AF:
AC:
85
AN:
172
European-Non Finnish (NFE)
AF:
AC:
25650
AN:
58532
Other (OTH)
AF:
AC:
566
AN:
1542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
930
1861
2791
3722
4652
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital Muscular Dystrophy, alpha-dystroglycan related Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.